Recurrent steatosis following liver transplant for non-alcoholic steatohepatitis (NASH) or cryptogenic cirrhosis (CC); Histomorphologic and clinical follow-up in 231 patients

被引：0

作者：

Punia, J. N. ^{[1
]}

Shah, V. V. ^{[1
]}

Sherbondy, M. A. ^{[1
]}

机构：

[1] Henry Ford Hosp, Detroit, MI 48202 USA

来源：

LABORATORY INVESTIGATION | 2007年 / 87卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1329

引用

页码：290A / 290A

页数：1

共 50 条

[41] FOLLOW-UP MANAGEMENT BASED ON DAG CIRCULATION COMBINED WITH PIO IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS [J].

Wang, Z. D. ;

Wang, X. J. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 :12-12

[42] Effects of sleeve gastrectomy on liver enzymes, non-alcoholic fatty liver disease-related fibrosis and steatosis scores in morbidly obese patients: first year follow-up [J].

Aksoy, Evrim Kahramanoglu ;

Goktas, Zeynep ;

Albuz, Ozgur ;

Akpinar, Muhammet Yener ;

Ozturk, Dogan ;

Bulus, Hakan ;

Uzman, Metin .

JOURNAL OF LABORATORY MEDICINE, 2019, 43 (02) :115-122

[43] Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/Non-Alcoholic Fatty Liver Disease (NAFLD) Registry [J].

Younossi, Zobair M. ;

Yilmaz, Yusuf ;

Yu, Ming-Lung ;

Wong, Vincent Wai-Sun ;

Fernandez, Marlen Castellanos ;

Isakov, Vasily A. ;

Duseja, Ajay K. ;

Mendez-Sanchez, Nahum ;

Eguchi, Yuichiro ;

Bugianesi, Elisabetta ;

Burra, Patrizia ;

George, Jacob ;

Fan, Jian-Gao ;

Papatheodoridis, George, V ;

Chan, Wah Kheong ;

Alswat, Khalid ;

Saeed, Hamid S. ;

Singal, Ashwani K. ;

Romero-Gomez, Manuel ;

Gordon, Stuart C. ;

Roberts, Stuart K. ;

El Kassas, Mohamed ;

Kugelmas, Marcelo ;

Ong, Janus P. ;

Alqahtani, Saleh ;

Ziayee, Mariam ;

Lam, Brian ;

Younossi, Issah ;

Racila, Andrei ;

Henry, Linda ;

Stepanova, Maria ;

Council, Global Nash .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) :2296-2306

[44] Emricasan (IDN-6556) Orally for 6 Months in Patients with Non-alcoholic Steatohepatitis (NASH) Cirrhosis Decreases the Progression of MELD score and Improves Liver Function [J].

Frenette, Catherine T. ;

Morelli, Giuseppe ;

Shiffman, Mitchell L. ;

Frederick, R. Todd ;

Rubin, Raymond ;

Fallon, Michael B. ;

Robinson, James M. ;

Yamashita, Mason ;

Spada, Alfred P. ;

Chan, Jean L. ;

Hagerty, David .

HEPATOLOGY, 2016, 64 :1044A-1044A

[45] Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan [J].

Toyoda H. ;

Kumada T. ;

Kiriyama S. ;

Tanikawa M. ;

Hisanaga Y. ;

Kanamori A. ;

Tada T. .

BMC Research Notes, 4 (1)

[46] PREDICTED LONG-TERM CLINICAL OUTCOMES OF OBETICHOLIC ACID (OCA) FOR THE TREATMENT OF PATIENTS WITH ADVANCED FIBROSIS WITHOUT CIRRHOSIS DUE TO NON-ALCOHOLIC STEATOHEPATITIS (NASH) COMPARED TO STANDARD OF CARE IN THE USA [J].

Barritt, A. Sidney ;

Brixner, Diana ;

Noureddin, Mazen ;

Chaiyakunapruk, Nathorn ;

Pais, Raluca ;

Green, William ;

Anaya, Pablo ;

Cure, Sandrine ;

Strauss, Marcie ;

Zur, Richard .

HEPATOLOGY, 2020, 72 :936A-937A

[47] Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up [J].

Ikeda, Suguru ;

Sugihara, Takaaki ;

Kihara, Takuya ;

Matsuki, Yukako ;

Nagahara, Takakazu ;

Takata, Tomoaki ;

Kitao, Sonoko ;

Okura, Tsuyoshi ;

Yamamoto, Kazuhiro ;

Isomoto, Hajime .

DIAGNOSTICS, 2021, 11 (12)

[48] RISK EVOLUTION OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS UNDER METHOTREXATE TREATMENT. A TWO-YEAR FOLLOW-UP IN ROUTINE CLINICAL PRACTICE [J].

de Ardanaz, L. Sarabia ;

Albaladejo, L. Perez ;

Fhafah, Z. Echerei ;

Navarrete, F. J. Godoy ;

Lucena, A. M. Cabezas ;

de la Torre, M. Ramirez ;

Onate, I. Anon .

ANNALS OF THE RHEUMATIC DISEASES, 2025, 84

[49] Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma [J].

Kawamura, Yusuke ;

Arase, Yasuji ;

Ikeda, Kenji ;

Seko, Yuya ;

Imai, Norihiro ;

Hosaka, Tetsuya ;

Kobayashi, Masahiro ;

Saitoh, Satoshi ;

Sezaki, Hitomi ;

Akuta, Norio ;

Suzuki, Fumitaka ;

Suzuki, Yoshiyuki ;

Ohmoto, Yuki ;

Amakawa, Kazuhisa ;

Tsuji, Hiroshi ;

Kumada, Hiromitsu .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (02) :253-261

[50] Bile Acid and Steroid Transporter OSTα/β is Over-Expressed in Liver from Patients With Non-alcoholic Steatohepatitis (NASH) and Primary Biliary Cirrhosis (PBC), and Modulated by Drugs Using a Novel In Vitro Cell System [J].

Malinen, Melina ;

Beaudoin, James ;

Ali, Izna ;

Brouwer, Kim L. .

HEPATOLOGY, 2017, 66 :1089A-1089A

← 1 2 3 4 5 →